Home
About
FAQ
History (4)
Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment.
Health care law versus constitutional law.
Limited proteolysis as a structural probe of the soluble alpha-glycerophosphate oxidase from Streptococcus sp.
Plasma trans-fatty acid concentrations in fasting adults declined from NHANES 1999-2000 to 2009-2010.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment.
Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003 Nov-Dec; 65(6):963-70.
View in:
PubMed
subject areas
Anti-Anxiety Agents
Anxiety
Anxiety Disorders
Attitude to Health
Clinical Trials as Topic
Combined Modality Therapy
Comorbidity
Dyspnea
Exercise Therapy
Humans
Panic Disorder
Prevalence
Pulmonary Disease, Chronic Obstructive
Quality of Life
Respiratory Function Tests
authors with profiles
Gretchen A. Brenes PhD